DAR vs REGN · P/E 45, rev $5.72B vs P/E 14, rev $14.34B
Darling Ingredients Inc (DAR) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Darling Ingredients Inc (DAR) is a packaged foods company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported DAR revenue for 2024-12-28 was $5.72B. Net income was $285.8M. Revenue was down 15.8% from 2023-12-30 to 2024-12-28. DAR currently screens at market cap $9.78B and trailing P/E 44.6.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
DAR currently screens at market cap $9.78B and trailing P/E 44.6. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the DAR and REGN stock pages for the full models.
Not investment advice.